Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh
Clinical trial NCT06449235 · UNKNOWN
Trial details
- NCT number
- NCT06449235
- Sponsor
- Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-01
- Primary completion
- 2025-04-01
- Enrollment
- 938
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.